HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Heart Rhythm

Volumn 10, Issue 12, 2013, Pages 1932-1963

  Priori, Silvia G ^a   Wilde, Arthur A ^b   Horie, Minoru ^c   Cho, Yongkeun ^d   Behr, Elijah R ^e   Berul, Charles ^f   Blom, Nico ^g   Brugada, Josep ^h   Chiang, Chern En ⁱ   Huikuri, Heikki ^j   Kannankeril, Prince ^k   Krahn, Andrew ^l   Leenhardt, Antoine ^m   Moss, Arthur ⁿ   Schwartz, Peter J ^o   Shimizu, Wataru ^p   Tomaselli, Gordon ^q   Tracy, Cynthia ^a,r  

^a IRCCS   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d Kyungpook National University   (South Korea)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^j OULU UNIVERSITY HOSPITAL   (Finland)

^k MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^m BICHAT HOSPITAL   (France)

ⁿ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^o UNIVERSITY OF PAVIA   (Italy)

^p NIPPON MEDICAL SCHOOL   (Japan)

^q JOHNS HOPKINS UNIVERSITY   (United States)

^r GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; ISOPRENALINE; METOPROLOL; NADOLOL; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; VERAPAMIL;

ADD ON THERAPY; ARTICLE; BRUGADA SYNDROME; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CATHETER ABLATION; CLINICAL FEATURE; CONSULTATION; DIFFERENTIAL DIAGNOSIS; EARLY REPOLARIZATION; ELECTROCARDIOGRAM; EXERCISE TEST; FAINTNESS; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HEART ARREST; HEART ARRHYTHMIA; HEART DENERVATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PALPITATION; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IDIOPATHIC VENTRICULAR FIBRILLATION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; INHERITANCE; LEFT CARDIAC SYMPATHETIC DENERVATION; LIFESTYLE MODIFICATION; LONG QT SYNDROME; LONG QT SYNDROME 1; LONG QT SYNDROME 2; LONG QT SYNDROME 3; PATIENT CARE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE CARDIAC CONDUCTION DISEASE; RISK ASSESSMENT; SHORT QT SYNDROME; ST SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; THORAX PAIN;

ARRHYTHMIAS, CARDIAC; CONGRESSES AS TOPIC; CONSENSUS; DISEASE MANAGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SYNDROME;

EID: 84889856570     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.05.014     Document Type: Article

References (242)

1. M.J. Ackerman, S.G. Priori, and S. Willems HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 2011 1308 1339
2. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
3. Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-2671.
4. S.A. Strickberger, D.W. Benson, and I. Biaggioni AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society Circulation 113 2006 316 327
5. P.J. Schwartz, M. Stramba- Badiale, and L. Crotti Prevalence of the congenital long-QT syndrome Circulation 120 2009 1761 1767
6. M.E. Curran, I. Splawski, and K.W. Timothy A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell 80 1995 795 803
7. Q. Wang, J. Shen, and I. Splawski SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome Cell 80 1995 805 811
8. Q. Wang, M.E. Curran, and I. Splawski Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias Nat Genet 12 1996 17 23
9. L. Crotti, M.C. Monti, and R. Insolia NOS1AP is a genetic modifier of the long-QT syndrome Circulation 120 2009 1657 1663
10. J.N. Johnson, D.J. Tester, and J. Perry Prevalence of early-onset atrial fibrillation in congenital long QT syndrome Heart Rhythm 5 2008 704 709
11. S. Zellerhoff, R. Pistulli, and G. Monnig Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study J Cardiovasc Electrophysiol 20 2009 401 407
12. P.J. Schwartz, S.G. Priori, and C. Spazzolini Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias Circulation 103 2001 89 95
13. S.G. Priori, P.J. Schwartz, and C. Napolitano Risk stratification in the long-QT syndrome N Engl J Med 348 2003 1866 1874
14. A.J. Moss, W. Zareba, and J. Benhorin ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome Circulation 92 1995 2929 2934
15. P.J. Schwartz, and A. Malliani Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome Am Heart J 89 1975 45 50
16. G. Malfatto, G. Beria, and S. Sala Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome J Am Coll Cardiol 23 1994 296 301
17. P.J. Schwartz, and L. Crotti QTc behavior during exercise and genetic testing for the long-QT syndrome Circulation 124 2011 2181 2184
18. P.J. Schwartz, A.J. Moss, and G.M. Vincent Diagnostic criteria for the long QT syndrome. An update Circulation 88 1993 782 784
19. I. Goldenberg, S. Horr, and A.J. Moss Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals J Am Coll Cardiol 57 2011 51 59
20. S. Viskin, P.G. Postema, and Z.A. Bhuiyan The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome J Am Coll Cardiol 55 2010 1955 1961
21. R.W. Sy, C. van der Werf, and I.S. Chattha Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands Circulation 124 2011 2187 2194
22. J.M. Horner, M.M. Horner, and M.J. Ackerman The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome Heart Rhythm 8 2011 1698 1704
23. H. Vyas, J. Hejlik, and M.J. Ackerman Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response Circulation 113 2006 1385 1392
24. W. Shimizu, T. Noda, and H. Takaki Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome Heart Rhythm 1 2004 276 283
25. P.J. Schwartz, C. Spazzolini, and L. Crotti The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome Circulation 113 2006 783 790
26. I. Splawski, K.W. Timothy, and L.M. Sharpe Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
27. A. Barsheshet, I. Goldenberg, and J. O-Uchi Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome Circulation 125 2012 1988 1996
28. D. Migdalovich, A.J. Moss, and C.M. Lopes Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome Heart Rhythm 8 2011 1537 1543
29. A.J. Moss, W. Zareba, and E.S. Kaufman Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel Circulation 105 2002 794 799
30. W. Shimizu, A.J. Moss, and A.A. Wilde Genotype-phenotype aspects of type 2 long QT syndrome J Am Coll Cardiol 54 2009 2052 2062
31. L. Crotti, C. Spazzolini, and P.J. Schwartz The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification Circulation 116 2007 2366 2375
32. C. Donger, I. Denjoy, and M. Berthet KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome Circulation 96 1997 2778 2781
33. I. Goldenberg, A.J. Moss, and D.R. Peterson Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome Circulation 117 2008 2184 2191
34. S.G. Priori, C. Napolitano, and P.J. Schwartz Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers JAMA 292 2004 1341 1344
35. P.J. Schwartz, C. Spazzolini, and L. Crotti All LQT3 patients need an ICD: true or false? Heart Rhythm 6 2009 113 120
36. C. Spazzolini, J. Mullally, and A.J. Moss Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy J Am Coll Cardiol 54 2009 832 837
37. E.H. Locati, W. Zareba, and A.J. Moss Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry Circulation 97 1998 2237 2244
38. J.N. Johnson, and M.J. Ackerman Competitive sports participation in athletes with congenital long QT syndrome JAMA 308 2012 764 765
39. P. Chockalingam, L. Crotti, and G. Girardengo Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol J Am Coll Cardiol 60 2012 2092 2099
40. C. Jons, A.J. Moss, and I. Goldenberg Risk of fatal arrhythmic events in long QT syndrome patients after syncope J Am Coll Cardiol 55 2010 783 788
41. W. Zareba, A.J. Moss, and J.P. Daubert Implantable cardioverter defibrillator in high-risk long QT syndrome patients J Cardiovasc Electrophysiol 14 2003 337 341
42. P.J. Schwartz, C. Spazzolini, and S.G. Priori Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry Circulation 122 2010 1272 1282
43. J.M. Horner, M. Kinoshita, and T.L. Webster Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience Heart Rhythm 7 2010 1616 1622
44. G.M. Vincent, P.J. Schwartz, and I. Denjoy High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures" Circulation 119 2009 215 221
45. M.E. Alexander, F. Cecchin, and E.P. Walsh Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics J Cardiovasc Electrophysiol 15 2004 72 76
46. E.S. Kaufman, S. McNitt, and A.J. Moss Risk of death in the long QT syndrome when a sibling has died Heart Rhythm 5 2008 831 836
47. P.J. Schwartz, S.G. Priori, and M. Cerrone Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome Circulation 109 2004 1826 1833
48. A.J. Moss, and J. McDonald Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome N Engl J Med 285 1971 903 904
49. K. Ouriel, and A.J. Moss Long QT syndrome: an indication for cervicothoracic sympathectomy Cardiovasc Surg 3 1995 475 478
50. A. Odero, A. Bozzani, and G.M. De Ferrari Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy Heart Rhythm 7 2010 1161 1165
51. C.A. Collura, J.N. Johnson, and C. Moir Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery Heart Rhythm 6 2009 752 759
52. + channel blockade and to increases in heart rate. Implications for gene-specific therapy Circulation 92 1995 3381 3386
53. A.J. Moss, J.R. Windle, and W.J. Hall Safety and efficacy of flecainide in subjects with long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial Ann Noninvasive Electrocardiol 10 4 Suppl 2005 59 66
54. A.J. Moss, W. Zareba, and K.Q. Schwarz Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome J Cardiovasc Electrophysiol 19 2008 1289 1293
55. C. Antzelevitch, P. Brugada, and M. Borggrefe Brugada syndrome: report of the second consensus conference Heart Rhythm 2 2005 429 440
56. C.R. Bezzina, W. Shimizu, and P. Yang Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction Circulation 113 2006 338 344
57. J.M. Di Diego, J.M. Cordeiro, and R.J. Goodrow Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males Circulation 106 2002 2004 2011
58. W. Shimizu, K. Matsuo, and Y. Kokubo Sex hormone and gender difference: role of testosterone on male predominance in Brugada syndrome J Cardiovasc Electrophysiol 18 2007 415 421
59. Y. Mizusawa, and A.A. Wilde Brugada syndrome Circ Arrhythm Electrophysiol 5 2012 606 616
60. F. van Hoorn, M.E. Campian, and A. Spijkerboer SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility PLoS One 7 2012 e42037
61. O. Catalano, S. Antonaci, and G. Moro Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities Eur Heart J 30 2009 2241 2248
62. A. Sarkozy, A. Sorgente, and T. Boussy The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern Eur Heart J 32 2011 2153 2160
63. K. Miyamoto, M. Yokokawa, and K. Tanaka Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome Am J Cardiol 99 2007 53 57
64. S. Nagase, S. Hiramatsu, and H. Morita Electroanatomical correlation of repolarization abnormalities in Brugada syndrome: detection of type 1 electrocardiogram in the right ventricular outflow tract J Am Coll Cardiol 56 2010 2143 2145
65. W. Shimizu Acquired forms of the Brugada syndrome J Electrocardiol 38 4 Suppl 2005 22 25
66. A.S. Amin, E.A. de Groot, and J.M. Ruijter Exercise-induced ECG changes in Brugada syndrome Circ Arrhythm Electrophysiol 2 2009 531 539
67. H. Makimoto, E. Nakagawa, and H. Takaki Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome J Am Coll Cardiol 56 2010 1576 1584
68. T. Ikeda, H. Sakurada, and K. Sakabe Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification J Am Coll Cardiol 37 2001 1628 1634
69. H. Morita, K.F. Kusano, and D. Miura Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome Circulation 118 2008 1697 1704
70. S.G. Priori, M. Gasparini, and C. Napolitano Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry J Am Coll Cardiol 59 2012 37 45
71. H. Makimoto, S. Kamakura, and N. Aihara Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram Heart Rhythm 9 2012 242 248
72. J. Brugada, R. Brugada, and C. Antzelevitch Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3 Circulation 105 2002 73 78
73. J. Brugada, R. Brugada, and P. Brugada Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest Circulation 108 2003 3092 3096
74. Brugada P., Brugada R., Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-292; discussion 279-292.
75. S.G. Priori, C. Napolitano, and M. Gasparini Natural history of Brugada syndrome: insights for risk stratification and management Circulation 105 2002 1342 1347
76. L. Eckardt, V. Probst, and J.P. Smits Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome Circulation 111 2005 257 263
77. P. Brugada, and J. Brugada Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report J Am Coll Cardiol 20 1992 1391 1396
78. S. Kamakura, T. Ohe, and K. Nakazawa Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3 Circ Arrhythm Electrophysiol 2 2009 495 503
79. J. Brugada, R. Brugada, and P. Brugada Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease Circulation 97 1998 457 460
80. B. Benito, A. Sarkozy, and L. Mont Gender differences in clinical manifestations of Brugada syndrome J Am Coll Cardiol 52 2008 1567 1573
81. A.K. Gehi, T.D. Duong, and L.D. Metz Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis J Cardiovasc Electrophysiol 17 2006 577 583
82. H. Morita, Kusano-Fukushima, and S. Nagase Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome J Am Coll Cardiol 40 2002 1437 1444
83. K.F. Kusano, K. M Taniyama, and K. Nakamura Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds J Am Coll Cardiol 51 2008 1169 1175
84. C. Giustetto, S. Drago, and P.G. Demarchi Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study Europace 11 2009 507 513
85. V. Probst, C. Veltmann, and L. Eckardt Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry Circulation 121 2010 635 643
86. P.C. Viswanathan, D.W. Benson, and J.R. Balser A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation J Clin Invest 111 2003 341 346
87. P.G. Meregalli, H.L. Tan, and V. Probst Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies Heart Rhythm 6 2009 341 348
88. S. Poelzing, C. Forleo, and M. Samodell SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene Circulation 114 2006 368 376
89. F. Sacher, V. Probst, and Y. Iesaka Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study Circulation 114 2006 2317 2324
90. A. Sarkozy, T. Boussy, and G. Kourgiannides Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome Eur Heart J 28 2007 334 344
91. R. Rosso, A. Glick, and M. Glikson Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU) Isr Med Assoc J 10 2008 435 439
92. P. Maury, M. Hocini, and M. Haissaguerre Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options Indian Pacing Electrophysiol J 5 2005 25 34
93. M.F. Marquez, A. Bonny, and E. Hernandez-Castillo Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review Heart Rhythm 9 2012 1995 2000
94. P.A. Schweizer, R. Becker, and H.A. Katus Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine Clin Res Cardiol 99 2010 467 470
95. M. Kakishita, T. Kurita, and K. Matsuo Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy J Am Coll Cardiol 36 2000 1646 1653
96. M. Haissaguerre, F. Extramiana, and M. Hocini Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes Circulation 108 2003 925 928
97. J.P. Darmon, S. Bettouche, and P. Deswardt Radiofrequency ablation of ventricular fibrillation and multiple right and left atrial tachycardia in a patient with Brugada syndrome J Interv Card Electrophysiol 11 2004 205 209
98. E. Nakagawa, M. Takagi, and H. Tatsumi Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome Circ J 72 2008 1025 1029
99. H. Morita, D.P. Zipes, and S.T. Morita Epicardial ablation eliminates ventricular arrhythmias in an experimental model of Brugada syndrome Heart Rhythm 6 2009 665 671
100. K. Nademanee, G. Veerakul, and P. Chandanamattha Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium Circulation 123 2011 1270 1279
101. P. Coumel, J. Fidelle, and V. Lucet Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases Br Heart J 40 Suppl 1978 28 37
102. A. Leenhardt, V. Lucet, and I. Denjoy Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients Circulation 91 1995 1512 1519
103. S.G. Priori, C. Napolitano, and N. Tiso Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
104. P.J. Laitinen, K.M. Brown, and K. Piippo Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 2001 485 490
105. H. Lahat, E. Pras, and T. Olender A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378 1384
106. H. Lahat, M. Eldar, and E. Levy-Nissenbaum Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21 Circulation 103 2001 2822 2827
107. A. Medeiros-Domingo, Z.A. Bhuiyan, and D.J. Tester The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis J Am Coll Cardiol 54 2009 2065 2074
108. A.L. Vega, D.J. Tester, and M.J. Ackerman Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia Circ Arrhythm Electrophysiol 2 2009 540 547
109. Z.A. Bhuiyan, M.A. Hamdan, and E.T. Shamsi A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22 J Cardiovasc Electrophysiol 18 2007 1060 1066
110. P.J. Mohler, I. Splawski, and C. Napolitano A cardiac arrhythmia syndrome caused by loss of ankyrin-B function Proc Natl Acad Sci U S A 101 2004 9137 9142
111. N. Roux-Buisson, M. Cacheux, and A. Fourest-Lieuvin Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human Hum Mol Genet 21 2012 2759 2767
112. M. Nyegaard, M.T. Overgaard, and M.T. Sondergaard Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death Am J Hum Genet 91 2012 703 712
113. N. Sumitomo, K. Harada, and M. Nagashima Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death Heart 89 2003 66 70
114. S.G. Priori, C. Napolitano, and M. Memmi Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 2002 69 74
115. M. Hayashi, I. Denjoy, and F. Extramiana Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia Circulation 119 2009 2426 2434
116. P. Kazemian, M.H. Gollob, and A. Pantano A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by beta-blocker therapy Can J Cardiol 27 870 2011 e7 e10
117. N. Sumitomo, H. Sakurada, and K. Taniguchi Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia Circ J 71 2007 1606 1609
118. C. van der Werf, I. Nederend, and N. Hofman Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives Circ Arrhythm Electrophysiol 5 2012 748 756
119. M.R. di Barletta, S. Viatchenko-Karpinski, and A. Nori Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia Circulation 114 2006 1012 1019
120. S. de la Fuente, I.M. Van Langen, and A.V. Postma A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations Pacing Clin Electrophysiol 31 2008 916 919
121. A.V. Postma, I. Denjoy, and T.M. Hoorntje Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia Circ Res 91 2002 e21 e26
122. N. Roux-Buisson, G. Egea, and I. Denjoy Germline and somatic mosaicism for a mutation of the ryanodine receptor type 2 gene: implication for genetic counselling and patient caring Europace 13 2011 130 132
123. C. van der Werf, A.H. Zwinderman, and A.A. Wilde Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments Europace 14 2012 175 183
124. L. Venetucci, M. Denegri, and C. Napolitano Inherited calcium channelopathies in the pathophysiology of arrhythmias Nat Rev Cardiol 9 2012 561 575
125. R. Rosso, J.M. Kalman, and O. Rogowski Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 4 2007 1149 1154
126. H. Swan, P. Laitinen, and K. Kontula Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations J Cardiovasc Electrophysiol 16 2005 162 166
127. C. van der Werf, P.J. Kannankeril, and F. Sacher Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia J Am Coll Cardiol 57 2011 2244 2254
128. H. Watanabe, N. Chopra, and D. Laver Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans Nat Med 15 2009 380 383
129. A.A. Wilde, Z.A. Bhuiyan, and L. Crotti Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia N Engl J Med 358 2008 2024 2029
130. J. Atallah, F. Fynn-Thompson, and F. Cecchin Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias Ann Thorac Surg 86 2008 1620 1625
131. R. Gopinathannair, B. Olshansky, and M. Iannettoni Delayed maximal response to left cardiac sympathectomy for catecholaminergic polymorphic ventricular tachycardia Europace 12 2010 1035 1039
132. S.Y. Chen, G. Cucchiaro, and G. Bushman The role of thoracic epidural blockade in predicting responsiveness to left sympathetic denervation in patients with catecholaminergic polymorphic ventricular tachycardia J Cardiothorac Vasc Anesth 25 2011 844 846
133. M.A. Coleman, J.M. Bos, and J.M. Johnson Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome Circ Arrhythm Electrophysiol 5 2012 782 788
134. T. Kaneshiro, Y. Naruse, and A. Nogami Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation Circ Arrhythm Electrophysiol 5 2012 e14 e17
135. I. Gussak, P. Brugada, J.m. Brugada Idiopathic short QT interval: a new clinical syndrome? Cardiology 94 2000 99 102
136. F. Gaita, C. Giustetto, and F. Bianchi Short QT Syndrome: a familial cause of sudden death Circulation 108 2003 965 970
137. R. Brugada, K. Hong, and R. Dumaine Sudden death associated with short-QT syndrome linked to mutations in HERG Circulation 109 2004 30 35
138. C. Bellocq, A.C. van Ginneken, and C.R. Bezzina Mutation in the KCNQ1 gene leading to the short QT-interval syndrome Circulation 109 2004 2394 2397
139. C. Giustetto, R. Schimpf, and A. Mazzanti Long-term follow-up of patients with short QT syndrome J Am Coll Cardiol 58 2011 587 595
140. S.G. Priori, S.V. Pandit, and I. Rivolta A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene Circ Res 96 2005 800 807
141. C. Antzelevitch, G.D. Pollevick, and J.M. Cordeiro Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death Circulation 115 2007 442 449
142. M.H. Gollob, C.J. Redpath, and J.D. Roberts The short QT syndrome: proposed diagnostic criteria J Am Coll Cardiol 57 2011 802 812
143. P. Bjerregaard Proposed diagnostic criteria for short QT syndrome are badly founded J Am Coll Cardiol 58 2011 549 550 author reply 550-551
144. C. Veltmann, and M. Borggrefe Arrhythmias: a "Schwartz score" for short QT syndrome Nat Rev Cardiol 8 2011 251 252
145. A. Funada, K. Hayashi, and H. Ino Assessment of QT intervals and prevalence of short QT syndrome in Japan Clin Cardiol 31 2008 270 274
146. J.W. Mason, and D.J. Ramseth Chanter DO, et al. Electrocardiographic reference ranges derived from 79,743 ambulatory subjects J Electrocardiol 40 2007 228 234
147. R. Kobza, M. Roos, and B. Niggli Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts Heart Rhythm 6 2009 652 657
148. O. Anttonen, M.J. Junttila, and H. Rissanen Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population Circulation 116 2007 714 720
149. F. Gaita, C. Giustetto, and F. Bianchi Short QT syndrome: pharmacological treatment J Am Coll Cardiol 43 2004 1494 1499
150. M.M. Gallagher, G. Magliano, and Y.G. Yap Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons Am J Cardiol 98 2006 933 935
151. J.J. Osborn Experimental hypothermia; respiratory and blood pH changes in relation to cardiac function Am J Physiol 175 1953 389 398
152. C. Antzelevitch, and G.X. Yan J wave syndromes Heart Rhythm 7 2010 549 558
153. M. Haissaguerre, N. Derval, and F. Sacher Sudden cardiac arrest associated with early repolarization N Engl J Med 358 2008 2016 2023
154. R. Rosso, E. Kogan, and B. Belhassen J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance J Am Coll Cardiol 52 2008 1231 1238
155. A. Abe, T. Ikeda, and T. Tsukada Circadian variation of late potentials in idiopathic ventricular fibrillation associated with J waves: insights into alternative pathophysiology and risk stratification Heart Rhythm 7 2010 675 682
156. G.B. Nam, K.H. Ko, and J. Kim Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome Eur Heart J 31 2010 330 339
157. N. Derval, C.S. Simpson, and D.H. Birnie Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry J Am Coll Cardiol 58 2011 722 728
158. R. Rosso, A. Adler, and A. Halkin Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective Heart Rhythm 8 2011 923 929
159. J.T. Tikkanen, O. Anttonen, and M.J. Junttila Long-term outcome associated with early repolarization on electrocardiography N Engl J Med 361 2009 2529 2537
160. M.F. Sinner, W. Reinhard, and M. Muller Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA) PLoS Med 7 2010 e1000314
161. D. Haruta, K. Matsuo, and A. Tsuneto Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram Circulation 123 2011 2931 2937
162. R.B. Patel, J. Ng, and V. Reddy Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease Circ Arrhythm Electrophysiol 3 2010 489 495
163. P.A. Noseworthy, J.T. Tikkanen, and K. Porthan The early repolarization pattern in the general population: clinical correlates and heritability J Am Coll Cardiol 57 2011 2284 2289
164. M.J. Junttila, S.J. Sager, and M. Freiser Inferolateral early repolarization in athletes J Interv Card Electrophysiol 31 2011 33 38
165. A. Sarkozy, G.B. Chierchia, and G. Paparella Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome Circ Arrhythm Electrophysiol 2 2009 154 161
166. H. Watanabe, T. Makiyama, and T. Koyama High prevalence of early repolarization in short QT syndrome Heart Rhythm 7 2010 647 652
167. L.M. Nunn, J. Bhar-Amato, and M.D. Lowe Prevalence of J-point elevation in sudden arrhythmic death syndrome families J Am Coll Cardiol 58 2011 286 290
168. W. Reinhard, B.M. Kaess, and R. Debiec Heritability of early repolarization: a population-based study Circ Cardiovasc Genet 4 2011 134 138
169. M. Haissaguerre, S. Chatel, and F. Sacher Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel J Cardiovasc Electrophysiol 20 2009 93 98
170. A. Medeiros-Domingo, B.H. Tan, and L. Crotti Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes Heart Rhythm 7 2010 1466 1471
171. E. Burashnikov, R. Pfeiffer, and H. Barajas-Martinez Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death Heart Rhythm 7 2010 1872 1882
172. H. Watanabe, A. Nogami, and K. Ohkubo Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization Circ Arrhythm Electrophysiol 4 2011 874 881
173. M.F. Sinner, K. Porthan, and P.A. Noseworthy A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern Heart Rhythm 9 2012 1627 1634
174. A. Uberoi, N.A. Jain, and M. Perez Early repolarization in an ambulatory clinical population Circulation 124 2011 2208 2214
175. J.T. Tikkanen, M.J. Junttila, and O. Anttonen Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome Circulation 123 2011 2666 2673
176. R. Rosso, E. Glikson, and B. Belhassen Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology Heart Rhythm 9 2012 225 229
177. S.H. Wu, X.X. Lin, and Y.J. Cheng Early repolarization pattern and risk for arrhythmia death: a meta-analysis J Am Coll Cardiol 61 2013 645 650
178. G.B. Nam, Y.H. Kim, and C. Antzelevitch Augmentation of J waves and electrical storms in patients with early repolarization N Engl J Med 358 2008 2078 2079
179. M. Haissaguerre, F. Sacher, and A. Nogami Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy J Am Coll Cardiol 53 2009 612 619
180. J.P. Smits, M.W. Veldkamp, and A.A. Wilde Mechanisms of inherited cardiac conduction disease Europace 7 2005 122 137
181. J.J. Schott, F. Charpentier, and H. Le Marec Progressive cardiac conduction disease I. Gussak, C. Antzelevitch, Electrical Diseases of the Heart 2008 Springer-Verlag London 564 576
182. 2+)activated cation channel gene TRPM4 in patients with cardiac conductance disturbances Hum Mutat 33 2012 109 117
183. M. Kruse, E. Schulze-Bahr, and V. Corfield Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I J Clin Invest 119 2009 2737 2744
184. C.M. Wolf, L. Wang, and R. Alcalai Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease J Mol Cell Cardiol 44 2008 293 303
185. C.M. Wolf, and C.I. Berul Inherited conduction system abnormalities: one group of diseases, many genes J Cardiovasc Electrophysiol 17 2006 446 455
186. J.H. van Berlo, W.G. de Voogt, and A.J. van der Kooi Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) 83 2005 79 83
187. M.R. Taylor, P.R. Fain, and G. Sinagra Natural history of dilated cardiomyopathy due to lamin A/C gene mutations J Am Coll Cardiol 41 2003 771 780
188. S.B. Parks, J.D. Kushner, and D. Nauman Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy Am Heart J 156 2008 161 169
189. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities Heart Rhythm 5 2008 e1 e62
190. I.A. van Rijsingen, E. Arbustini, and P.M. Elliott Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study J Am Coll Cardiol 59 2012 493 500
191. S.G. Priori, M. Borggrefe, and A.J. Camm Unexplained cardiac arrest. The need for a prospective registry Eur Heart J 13 1992 1445 1446
192. Circulation 95 1997 265 272
193. A.D. Krahn, J.S. Healey, and V. Chauhan Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) Circulation 120 2009 278 285
194. A. Mazzanti, and S.G. Priori Molecular autopsy for sudden unexplained death? Time to discuss pros and cons J Cardiovasc Electrophysiol 23 2012 1099 1102
195. S.G. Priori Arrhythmias: unexplained sudden cardiac death: back to clinical evaluation Nat Rev Cardiol 6 2009 678 679
196. R. Bai, C. Napolitano, and R. Bloise Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing Circ Arrhythm Electrophysiol 2 2009 6 15
197. H.J. Crijns, A.C. Wiesfeld, and J.L. Posma Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias Br Heart J 74 1995 408 412
198. B. Belhassen, and S. Viskin Management of idiopathic ventricular fibrillation: implantable defibrillators? antiarrhythmic drugs? Ann Noninvasive Electrocardiol 3 1998 125 128
199. C.A. Remme, E.F. Wever, and A.A. Wilde Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation Eur Heart J 22 2001 400 409
200. S. Knecht, F. Sacher, and M. Wright Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study J Am Coll Cardiol 54 2009 522 528
201. R.J. Myerburg, K.M. Kessler, and A. Castellanos Sudden cardiac death. Structure, function, and time-dependence of risk Circulation 85 1 Suppl 1992 I2 I10
202. E. Behr, D.A. Wood, and M. Wright Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome Lancet 362 2003 1457 1459
203. E.R. Behr, A. Casey, and M. Sheppard Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death Heart 93 2007 601 605
204. T.J. Bowker, D.A. Wood, and M.J. Davies Sudden, unexpected cardiac or unexplained death in England: a national survey QJM 96 2003 269 279
205. M. Vatta, R. Dumaine, and G. Varghese Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome Hum Mol Genet 11 2002 337 345
206. H.F. Krous, J.B. Beckwith, and R.W. Byard Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach Pediatrics 114 2004 234 238
207. B.G. Winkel, A.G. Holst, and J. Theilade Nationwide study of sudden cardiac death in persons aged 1-35 years Eur Heart J 32 2011 983 990
208. D. Corrado, C. Basso, and G. Thiene Sudden cardiac death in young people with apparently normal heart Cardiovasc Res 50 2001 399 408
209. C. van der Werf, N. Hofman, and H.L. Tan Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands Heart Rhythm 7 2010 1383 1389
210. De Noronha S.V., Behr E., Papadakis M., et al. The importance of expert cardiac pathology for the investigation of sudden cardiac death; results from a British fast track cardiac pathology service 2011. August poster session presented at ESC Congress 2011, August 27-31, 2011, Paris, France.
211. R. Margey, A. Roy, and S. Tobin Sudden cardiac death in 14- to 35-year olds in Ireland from 2005 to 2007: a retrospective registry Europace 13 2011 1411 1418
212. R.E. Eckart, S.L. Scoville, and C.L. Campbell Sudden death in young adults: a 25-year review of autopsies in military recruits Ann Intern Med 141 2004 829 834
213. R. Puranik, C.K. Chow, and J.A. Duflou Sudden death in the young Heart Rhythm 2 2005 1277 1282
214. B.J. Maron Sudden death in young athletes N Engl J Med 349 2003 1064 1075
215. S.V. de Noronha, S. Sharma, and M. Papadakis Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study Heart 95 2009 1409 1414
216. C.M. McGarvey, M. O'Regan, and J. Cryan Sudden unexplained death in childhood (1-4 years) in Ireland: an epidemiological profile and comparison with SIDS Arch Dis Child 97 2012 692 697
217. S.S. Chugh, K. Reinier, and S. Balaji Population-based analysis of sudden death in children: The Oregon Sudden Unexpected Death Study Heart Rhythm 6 2009 1618 1622
218. F.L. Trachtenberg, E.A. Haas, and H.C. Kinney Risk factor changes for sudden infant death syndrome after initiation of back-to-sleep campaign Pediatrics 129 2012 630 638
219. C. Basso, M. Burke, and P. Fornes Guidelines for autopsy investigation of sudden cardiac death Virchows Arch 452 2008 11 18
220. M. Papadakis, H. Raju, and E.R. Behr Sudden cardiac death with autopsy findings of uncertain signficance: potential for erroneous interpretation Circ Arrhythm Electrophysiol 2013 May 13[Epub ahead of print]
221. H. Raju, M. Papadakis, and M. Govindan Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome J Am Coll Cardiol 57 2011 2340 2345
222. D.J. Tester, and M.J. Ackerman The role of molecular autopsy in unexplained sudden cardiac death Curr Opin Cardiol 21 2006 166 172
223. H.L. Tan, N. Hofman, and I.M. van Langen Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives Circulation 112 2005 207 213
224. E.R. Behr, C. Dalageorgou, and M. Christiansen Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families Eur Heart J 29 2008 1670 1680
225. S.G. Priori, and C. Napolitano Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies Circulation 113 2006 1130 1135
226. N. Hofman, H.L. Tan, and M. Alders Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 55 2010 2570 2576
227. L.M. Nunn, and P.D. Lambiase Genetics and cardiovascular disease: causes and prevention of unexpected sudden adult death: the role of the SADS clinic Heart 97 2011 1122 1127
228. J. Ingles, L. Yeates, and C. Semsarian The emerging role of the cardiac genetic counselor Heart Rhythm 8 2011 1958 1962
229. I.M. van Langen, D. Birnie, and N.J. Leschot Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J 24 2003 560 566
230. K.S. Hendriks, M.M. Hendriks, and E. Birnie Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome Heart Rhythm 5 2008 719 724
231. K.S. Hendriks, F.J. Grosfeld, and J.P. van Tintelen Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome Am J Med Genet A 138A 2005 107 112
232. K.S. Hendriks, F.J. Grosfeld, and A.A. Wilde High distress in parents whose children undergo predictive testing for long QT syndrome Community Genet 8 2005 103 113
233. I. Christiaans, I.M. van Langen, and E. Birnie Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective Am J Med Genet A 149A 2009 1444 1451
234. I. Christiaans, I.M. van Langen, and E. Birnie Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study Am J Med Genet A 149A 2009 602 612
235. E. Hoedemaekers Jaspers JP, Van Tintelen JP. The influence of coping styles and perceived control on emotional distress in persons at risk for a hereditary heart disease Am J Med Genet A 143A 2007 1997 2005
236. A. Hamang, G.E. Eide, and B. Rokne General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety: a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death Health Qual Life Outcomes 9 2011 100
237. I. Christiaans, T.M. Kok, and I.M. van Langen Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers Eur J Hum Genet 18 2010 251 253
238. I.M. van Langen, N. Hofman, and H.L. Tan Family and population strategies for screening and counselling of inherited cardiac arrhythmias Ann Med 36 Suppl 1 2004 116 124
239. I. Christiaans, E. Birnie, and G.J. Bonsel Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy Eur J Hum Genet 16 2008 1201 1207
240. L.L. Cohen, and M. Stolerman Walsh, et al. Challenges of genetic testing in adolescents with cardiac arrhythmia syndromes J Med Ethics 38 2012 163 167
241. J. Caldwell, N. Moreton, and N. Khan The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated Heart 98 2012 631 636
242. J. Ingles, P.R. Zodgekar, and L. Yeates Guidelines for genetic testing of inherited cardiac disorders Heart Lung Circ 20 2011 681 687